Patents Assigned to Finnzymes Oy
-
Publication number: 20130023423Abstract: Transposon nucleic acids comprising a transposon end sequence and a calibration sequence for DNA sequencing in the transposon end sequence. In one embodiment, the transposon end sequence is a Mu transposon end. A method for the generation of DNA fragmentation library based on a transposition reaction in the presence of a transposon end with the calibration sequence providing facilitated downstream handling of the produced DNA fragments, e.g., in the generation of sequencing templates.Type: ApplicationFiled: July 19, 2012Publication date: January 24, 2013Applicant: Finnzymes OyInventors: Ian Kavanagh, Laura-Leena Kiiskinen, Heli Haakana
-
Publication number: 20130017978Abstract: A method for the generation of DNA fragmentation library based on a transposition reaction in the presence of a transposon end with an engineered cleaveage site providing facilitated downstream handling of the produced DNA fragments, e.g., in the generation of sequencing templates. Transposon nucleic acids comprising a transposon end sequence and an engineered cleaveage site located in the sequence, e.g., in Mu transposon end sequence, are disclosed.Type: ApplicationFiled: July 9, 2012Publication date: January 17, 2013Applicant: Finnzymes OyInventors: Ian Kavanagh, Laura-Leena Kiiskinen, Heli Haakana
-
Publication number: 20120219957Abstract: The invention relates to a method of preparing a reaction mixture for Polymerase Chain Reaction (PCR) assay and a solution set for PCR. The method comprises providing a sample solution comprising a biological sample to be amplified in said PCR assay and first colorant providing the solution a first color, providing a reagent solution comprising at least one other substance required for performing said assay and second colorant providing the solution a second color different from the first color, and mixing the sample solution and the first reagent solution for providing a mixed solution to be subjected to the PCR process, the mixed solution having, due to said first and second colorants, a third color different from the first and second colors. The invention significantly aids in pipetting PCR assays.Type: ApplicationFiled: October 4, 2010Publication date: August 30, 2012Applicant: Finnzymes OyInventors: Jaakko Kurkela, Katja Eklin, Sanna Uusivirta
-
Patent number: 8192934Abstract: The present invention relates to genetic engineering and especially to the use of DNA transposition complex of bacteriophage Mu. In particular, the invention provides a gene transfer system for eukaryotic cells, wherein in vitro assembled Mu transposition complexes are introduced into a target cell and subsequently transposition into a cellular nucleic acid occurs. The invention further provides a kit for producing insertional mutations into the genomes of eukaryotic cells. The kit can be used, e.g., to generate insertional mutant libraries.Type: GrantFiled: September 9, 2011Date of Patent: June 5, 2012Assignee: Finnzymes OyInventors: Harri Savilahti, Mikko Frilander, Xiaojuan Meng, Anja Paatero, Maria Pajunen, Hikka Turakainen
-
Publication number: 20120082981Abstract: Polymorphisms are present throughout an organism's genome, and understanding which alleles are present in a particular organism's genome can be advantageous. When probing the identity of these alleles, one must minimize incorrect readings due to inefficiencies in the system. In hydrolysis probe applications, these inefficiencies may be due to over-activity of an exonuclease functionality that excises nucleotides from probes that are only partially, complementary to a region of a target. The present invention provides a mixture that contains a plurality of polymerases including one that has a 5??3? exonuclease functionality and one that lacks or substantially lacks it, each in a sufficient relative amount and concentration to increase efficiencies of the system.Type: ApplicationFiled: October 4, 2011Publication date: April 5, 2012Applicant: Finnzymes OyInventor: Jaakko Kurkela
-
Publication number: 20120015831Abstract: The present invention relates to genetic engineering and especially to the use of DNA transposition complex of bacteriophage Mu. In particular, the invention provides a gene transfer system for eukaryotic cells, wherein in vitro assembled Mu transposition complexes are introduced into a target cell and subsequently transposition into a cellular nucleic acid occurs. The invention further provides a kit for producing insertional mutations into the genomes of eukaryotic cells. The kit can be used, e.g., to generate insertional mutant libraries.Type: ApplicationFiled: September 9, 2011Publication date: January 19, 2012Applicant: Finnzymes OyInventors: Harri Savilahti, Mikko Frilander, Xiaojuan Meng, Anja Paatero, Maria Pajunen, Hilkka Turakainen
-
Publication number: 20110251080Abstract: The invention relates to a sample processing apparatus comprising a holder for a microtiter plate comprising a plurality of microwells, optical measurement unit for measuring optical responses of samples dosed to the microwells, and a computing unit configured to analyze the optical responses in order to detect dosing failures in said plurality of microwells, and if a dosing failure has been detected in one or more of the microwells, to communicate the existence of the dosing failure to a user of the apparatus through signaling means or to store data indicative of the dosing failure to data storage means for further use. In particular, the invention relates to detecting dosing failures in before, during and after a PCR process.Type: ApplicationFiled: April 1, 2011Publication date: October 13, 2011Applicant: FINNZYMES OYInventors: Jukka TUUNANEN, Jaakko Kurkela, Katja Eklin
-
Patent number: 8026052Abstract: The present invention relates to genetic engineering and especially to the use of DNA transposition complex of bacteriophage Mu. In particular, the invention provides a gene transfer system for eukaryotic cells, wherein in vitro assembled Mu transposition complexes are introduced into a target cell and subsequently transposition into a cellular nucleic acid occurs. The invention further provides a kit for producing insertional mutations into the genomes of eukaryotic cells. The kit can be used, e.g., to generate insertional mutant libraries.Type: GrantFiled: April 14, 2004Date of Patent: September 27, 2011Assignee: Finnzymes OyInventors: Harri Savilahti, Mikko Frilander, Xiaojuan Meng, Anja Paatero, Maria Pajunen, Hilkka Turakainen
-
Publication number: 20100173800Abstract: The present invention relates to genetic engineering and especially to the use of DNA transposition complex of bacteriophage Mu. In particular, the invention provides a gene transfer system for isolated human stem cells, wherein in vitro assembled Mu transposition complexes are introduced into a target cell and subsequently transposition into a cellular nucleic acid occurs. The invention further provides a kit for producing insertional mutations into the genomes of isolated human stem cells. The kit can be used, e.g., to generate insertional mutant libraries.Type: ApplicationFiled: July 4, 2008Publication date: July 8, 2010Applicant: FINNZYMES OYInventor: Harri Savilahti
-
Publication number: 20090191561Abstract: The present invention relates to the field of polymerase chain reaction (PCR) based diagnostic assays. More specifically, the present invention provides a PCR-method for detecting mastitis causing bacteria, particularly Staphylococcus aureus and coagulase negative staphylococci. The present invention also provides oligonucleotide primers and probes for use in said method.Type: ApplicationFiled: December 31, 2008Publication date: July 30, 2009Applicant: Finnzymes OyInventors: Jani Holopainen, Mikko Koskinen
-
Patent number: 7172882Abstract: The present invention describes an in vitro transposition-based methodology for generation of deletion derivatives of polypeptides. An artificial transposon containing at least partly within its transposon ends a modification with translation stop codons in three reading frames is provided. In the method, transposition complexes are assembled using the modified transposon and essentially random integrations into the target plasmid, containing a polypeptide coding nucleic acid of interest, are recovered as a plasmid pool. Subsequent manipulation steps including restriction enzyme digestions and ligation result in pools of mutant clones from which deletion derivatives of a polypeptide coding nucleic acid of interest and its respective deletion polypeptides could be produced.Type: GrantFiled: April 14, 2003Date of Patent: February 6, 2007Assignee: Finnzymes OyInventors: Harri Savilahti, Ville Tieaho
-
Patent number: 6593113Abstract: The present invention relates to an in vitro method for providing unique templates for DNA sequencing and to a kit, which can be used, when employing the selection method of this invention. The examined DNA is subjected to a DNA transposition reaction and to an amplification reaction. The amplification reaction is carried out in the presence of a fixed primer and a selective primer having a complementary sequence to the end of a transposon DNA. A transposition reaction can be carried out also in the presence of a transposon or transposons, which have different ends enabling the design of selective primers for both ends. Each size of the amplification products represents one template for a sequencing reaction.Type: GrantFiled: December 30, 1999Date of Patent: July 15, 2003Assignee: Finnzymes OyInventors: Tuomas Tenkanen, Timo Soininen, Harri Savilahti, Kirsi Multanen